Press release
United States Melanoma Therapeutics Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
Melanoma Therapeutics Market
The Global Melanoma Therapeutics Market reached US$ 5.40 billion in 2024 and is expected to reach US$ 8.35 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2025-2032.
Recent Mergers and acquisitions:
United States:
✅ In July 2025, IO Biotech initiated a pivotal Phase 3 trial (IOB-013/KN-D18) for its cancer vaccine Cylembio® in combination with KEYTRUDA® for advanced melanoma. The trial is progressing as planned, with results expected in Q3 2025.
✅ In March 2025, Replimune's RP1 melanoma therapy neared an FDA decision, with a PDUFA date set for July 2025. The company is preparing its commercial infrastructure for a potential launch.
✅ In August 2024, Roche announced plans to acquire Poseida Therapeutics for approximately $1.5 billion. Poseida's expertise in allogeneic CAR-T cell therapies is anticipated to complement Roche's oncology portfolio, including melanoma treatments
✅ In February 2024, Iovance Biotherapeutics received FDA accelerated approval for Lifileucel (Amtagvi), the first T-cell therapy for advanced melanoma after PD-1 and BRAF inhibitors. This approval marks a significant milestone in personalized cancer treatment.
Japan:
✅ In April 2025, the National Cancer Center Japan announced a new president, signaling a renewed focus on advancing cancer research and treatment strategies, including for melanoma.
✅ In January 2025, Japan launched the "ARCAD-Gastric" global clinical trial database project, aiming to enhance research capabilities, which may include studies on melanoma therapies.
✅ In September 2024, Astellas Pharma finalized its acquisition of a Japanese biotech company specializing in melanoma vaccines. This strategic acquisition aims to diversify Astellas's oncology portfolio and accelerate the development of melanoma immunotherapies.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/melanoma-therapeutics-market?sb
Melanoma Therapeutics are treatments designed to manage and cure melanoma, a serious form of skin cancer. These include targeted therapies, immunotherapies, chemotherapy, and surgical interventions, aimed at inhibiting tumor growth, preventing metastasis, and improving patient survival and quality of life.
Key Players:
=> Merck & Co., Inc., Bristol-Myers Squibb Company., Amgen, Inc., IOVANCE Biotherapeutics, Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Immunocore Holdings plc., Eisai Co., Ltd., and Delcath Systems, Inc. among others.
Growth Forecast Projected:
The Global Melanoma Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Melanoma Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=melanoma-therapeutics-market
Key Segments:
➥ By Type: Superficial Spreading Melanoma, Nodular Melanoma, Lentigo Maligna Melanoma, Acral Lentiginous Melanoma, Others
➥ By Therapy: Surgery, Immunotherapy (Pembrolizumab, Nivolumab, Ipilimumab, Lifileucel, Others), Targeted Therapy (BRAF Inhibitors, MEK Inhibitors, KIT Inhibitors), Chemotherapy, Radiation Therapy
Regional Analysis for Melanoma Therapeutics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Melanoma Therapeutics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Melanoma Therapeutics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/melanoma-therapeutics-market?sb
FAQ
What is the current size of the Melanoma Therapeutics Market?
A: In 2024, the Melanoma Therapeutics Market was valued at US$ 5.40 billion, reflecting its strong industry presence.
Q2: How large is the Melanoma Therapeutics Market expected to be by 2032?
A: By 2032, industry forecasts suggest the Melanoma Therapeutics Market will grow to around US$ 8.35 billion , demonstrating significant expansion.
Q3: What is the growth rate of the Melanoma Therapeutics Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2025 to 2032.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Melanoma Therapeutics Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities here
News-ID: 4194283 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Aerospace Coatings Market 2025 | Growth Drivers, Key Players & Inv …
Market Size and Growth
Aerospace Coatings market reached US$ 2.39 billion in 2024 and is expected to reach US$ 4.02 billion by 2032, growing with a CAGR of 6.70% during the forecast period 2025-2032.
Key Development & Recent Mergers and acquisitions:
United States: Industry Advancements
✅ In October 2025, AkzoNobel Aerospace Coatings launched an AS7489-certified training program during the NBAA event in Las Vegas. This initiative is designed to advance the adoption of…
United States Flight Simulator Market 2025 | Growth Drivers, Key Players & Inves …
Market Size and Growth
The Global Flight Simulator Market reached USD 6.8 billion in 2022 and is expected to reach USD 11.6 billion by 2030, growing with a CAGR of 7.0% during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ October 2025: Microsoft Flight Simulator unveiled two new beta test builds for Sim Update 4. These builds aim to refine the simulator's performance and introduce new features, ensuring an improved…
United States Anti Drone Market 2025 | Growth Drivers, Key Players & Investment …
Market Szie and Growth
Global Anti-Drone analyses the market size, shares, recent trends, competitive intelligence, and future market outlook. The market is expected to reach at a CAGR of 31.5% By 2030.
Key Development:
United States: Recent Anti-Drone Developments
✅ October 2025 - AeroVironment secured a $95.9 million U.S. Army contract to deliver the Freedom Eagle-1 kinetic interceptor. This system has successfully completed live-fire tests and is poised for deployment to counter emerging…
United States Hypersonic Weapons Market 2025 | Growth Drivers, Key Players & Inv …
Market Size and Growth
Global Hypersonic Weapons Market reached US$ 7.1 billion in 2022 and is expected to reach US$ 16.6 billion by 2030, growing with a CAGR of 11.2% during the forecast period 2023-2030.
Key Development:
✅ In October 2025, the U.S. military is advancing efforts to integrate hypersonic weapons with mobile launch platforms. Defense startup Castelion announced contracts to adapt its Blackbeard hypersonic strike system for use with U.S. Army systems…
More Releases for Melanoma
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period?
The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market?
The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt…
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market?
The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in…
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Amgen, Inc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Qiagen NV
• Sun Pharmaceutical Industries Ltd…
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
